How to Negotiate Startup Equity: A Practical Guide for Employees

Before you accept a startup equity offer, you need two things: enough information to evaluate the grant’s economics, and a clear list of which terms you can still negotiate. This guide covers both.

To evaluate the offer, get the share or option count, the fully diluted capitalization used to express your percentage, the exercise price and how grant-date fair market value was set, the vesting schedule, whether the award is an ISO or NSO, what happens if you leave, and how preferred-stock liquidation rights affect common-stock proceeds. An offer-letter promise is not the same as a board-approved grant—confirm the approved award documents match what you negotiated.

Terms employees commonly negotiate include grant size (and the percentage it represents on a stated capitalization), acceleration, vesting and cliff terms, the contractual post-termination exercise window, early-exercise rights, and refresher-grant policy. Flexibility depends on the role, compensation bands, available equity, and competing offers.

Companion guides: Startup Equity Compensation Guide, ISO vs. NSO, 83(b) Elections, and 409A Valuations.

01. Understand What You're Being Offered

Before you negotiate, identify exactly what is on the table:

Number of shares or options. Ask for the share count and its percentage of a stated capitalization. Owning 100,000 of 100 million outstanding shares represents 0.1% of outstanding stock. Options are rights to acquire shares; evaluate them using the stated fully diluted denominator and the exercise, vesting, and other award terms.

Percentage ownership. A raw share or option count is meaningless without the denominator used to express your percentage. Ask what percentage the grant represents, on which capitalization, and as of what date. There is no single universal “required” denominator—companies use different fully diluted conventions—so ask the company to clarify what is included: outstanding common, preferred on an as-converted basis, outstanding options and other awards, warrants, the unissued option reserve (without double-counting), and how SAFEs and convertible notes are modeled. Ask whether the quoted percentage is pre- or post-financing and what happens to it if a round closes. An option grant is a right to acquire stock, not present stock ownership. For how companies track this, see the cap table guide.

Exercise price (for options). Distinguish option count, strike (exercise) price, common-stock fair market value, preferred financing price, and any future exit value—they are different numbers. Preferred share price is not common FMV, and a 409A valuation is not “what the company is worth.” To qualify for the ordinary stock-option exemption from Section 409A, an NSO generally must have an exercise price at least equal to grant-date fair market value and satisfy the other stock-right conditions. A strike above FMV is not itself a 409A defect (it just reduces economic appeal). A strike below common FMV can create 409A problems for NSOs and other tax issues; ask how grant-date FMV was set. See Treas. Reg. §1.409A-1(b)(5).

Vesting schedule. A common market convention is four years with a one-year cliff (nothing for the first year, 25% at the one-year anniversary, then monthly over the next three years). That pattern is not a legal requirement. Variations—three-year vesting, six-month cliffs, back-loaded schedules—matter for how much you keep if you leave early. An acquisition does not automatically accelerate unvested equity unless your documents say so.

Option type: ISO or NSO. Ask which type you are receiving. ISOs require qualifying employment, corporate stock, and compliance with Section 422’s plan and grant requirements. They can provide favorable regular federal income-tax treatment, but AMT, exercise timing, holding periods, and liquidity can change the comparison. An LLC taxed as a partnership cannot issue ISOs on its membership interests; federal tax classification matters.

Practice Note: If the company won't tell you the total number of fully diluted shares, you cannot evaluate the offer. Insist on at least an approximate fully diluted count before accepting.

02. How to Evaluate Whether Your Offer Is Fair

Look at percentage, not share count. Emphasizing “50,000 options” without the fully diluted denominator tells you nothing about ownership.

Compare offers using the facts that actually differ. Role, seniority, funding stage, geography, salary tradeoffs, and grant duration all affect whether two packages are comparable. Confirm whether each stated percentage is measured before or after a financing and whether it includes the unissued pool. The same percentage can have very different economics at two companies. Do not rely on generic role-and-stage percentage charts; use current offers or dated compensation data for similar roles when you need a comparison point.

Calculate potential proceeds. Ask for exit scenarios showing what reaches common stock after debt, transaction costs, and preferred-stock liquidation rights. Apply your vested share count and subtract exercise costs and taxes. Multiplying an ownership percentage by a headline acquisition price works only under explicit assumptions about the capital structure and proceeds available to shareholders.

Example: 50,000 options at $0.25 cost $12,500 to exercise and represent 0.5% of 10 million fully diluted shares. Assume all options vest, no further dilution, no debt or transaction costs, and all preferred stock converts so proceeds are shared pro rata. A $100 million equity exit then gives $500,000 gross proceeds, or $487,500 after exercise cost and before taxes; a $500 million exit gives $2,487,500 after exercise cost. If preferred investors instead take liquidation preferences, these calculations do not apply. Common stock can receive nothing even when the company sells for a positive price. If you already exercised, the purchase price is also at risk.

Factor in dilution. Your percentage ordinarily changes; it is not permanently fixed at grant. New financings, convertible-security conversions, and pool increases can reduce it. For illustration, three rounds each diluting existing holders by 20% reduce 0.5% to 0.256%; four reduce it to 0.2048%. Those are assumptions, not a forecast. A larger company valuation does not guarantee a larger payout to common stock.

03. The Questions You Must Ask

Use these questions to clarify the offer before accepting. Several of these points also surface as red flags or negotiation mistakes later—ask them here first.

1. What is the total number of fully diluted shares?
This lets you calculate your actual ownership percentage. Refusal to share at least an approximate count is a reason to pause.

2. What is the current 409A valuation (common-stock fair market value per share)? Ask its effective date and whether a financing or other material event has occurred since. Ask how the exercise price relates to that FMV. Common-stock FMV is not interchangeable with the preferred financing price or a guaranteed exit value.

3. What is the most recent preferred share price, and what rights do those shares carry? Ask about liquidation preferences, participation, seniority, and conversion. Preferred investors may have economic and control rights your common shares lack. Request an exit-waterfall illustration rather than treating the preferred/common price gap as employee profit.

4. What is the vesting schedule, and is there a cliff?
Confirm the schedule and compare shares vested at realistic departure dates. Unusually back-loaded or longer schedules leave fewer shares vested if you leave earlier.

5. Are these ISOs or NSOs? Ask why the company selected that type and compare actual exercise and sale scenarios. Consultant status, employer tax classification, and the $100,000 first-exercisable limit may affect ISO availability. Neither label alone establishes the better after-tax outcome.

6. What happens to my options if I leave? Distinguish the contractual post-termination exercise period from ISO tax treatment. Obtain the contractual expiration date, treatment of each termination category (resignation, without-cause, for-cause, death, disability), and the original option term. Many agreements allow about 90 days after ordinary departure; others permit longer—do not say an ISO “expires after three months” unless the option terms say so. Separately, Section 422 generally requires exercise within three calendar months after employment ends for continued ISO treatment. If the contract allows exercise beyond that statutory window, the option may still be exercisable as a contract matter while losing ISO characterization (often taxed more like an NSO). The tax rule does not extend an expired contractual option. Calendar both deadlines; 90 days and three months are not interchangeable. Also distinguish: unvested awards typically forfeit; vested options remain subject to the exercise window; vested stock you already own is not automatically taken back unless a repurchase or similar right in the governing documents applies.

7. Is there an early exercise provision? Ask whether the award permits buying shares before vesting and what repurchase terms apply. Compare purchase cost, current fair market value, tax, liquidity, and loss risk. A low strike price does not establish a low taxable spread. Early exercise into restricted stock can make a timely 83(b) election important; ISO and NSO treatment differ.

8. Is there double-trigger acceleration? Read both triggers: a qualifying change in control and a qualifying termination within the specified period. Ask whether termination without cause and resignation for good reason are covered, how much accelerates, and what happens if the buyer does not assume or replace the award. Acquisition plus any termination does not automatically qualify.

9. What's the company's current burn rate and runway?
This tells you how long the company can operate before it needs more funding.

10. Can I sell these shares or options? Startup equity is usually not readily sold. Ask about transfer restrictions, right of first refusal (ROFR), company or board approval requirements, and securities-law limits. If there has been a secondary sale or tender offer, ask who was eligible, what limits applied, and whether any future program is committed—past deals do not guarantee another liquidity opportunity.

11. How is the option pool modeled in the quoted percentage? Ask how much of the reserve is unissued and whether the quoted fully diluted denominator already includes it. Grants from an already-counted reserve do not themselves increase that denominator. A pool increase or awards omitted from the original calculation can dilute the quoted percentage.

→ For more on double-trigger acceleration, see my Double-Trigger Acceleration guide.

04. A Practical Negotiation Framework

Ask which terms the company can change and who must approve them. A senior hire at an early-stage company may have more room on individual terms than an employee joining within later-stage compensation bands. Know which situation you are in before deciding where to push.

Seven steps that actually move the needle:

1. Get the facts. Share/option count, stated fully diluted denominator and date, strike, 409A/common FMV, preferred price and preferences, vesting, ISO vs. NSO, and post-termination exercise terms.
2. Model the economics. Ownership % on the stated capitalization, exercise cost, dilution assumptions, and exit-waterfall scenarios for common stock—not headline valuation alone.
3. Map the approval path. Offer letter vs. board-approved grant; who can change size, acceleration, or exercise-window terms.
4. Prioritize asks. Lead with grant size / stated percentage, then realization terms: acceleration, vesting/cliff, contractual post-termination exercise window, early-exercise rights, and refresher policy.
5. Trade cash and equity deliberately. If you adjust base salary against equity (or the reverse), model cash needs, exercise funding, and illiquidity—not a slogan about “believing in the upside.”
6. Put agreed terms in writing. One short ask that states the denominator and the documents that must match. Example: “The proposed 25,000 options represent 0.25% on the stated 10-million-share fully diluted denominator. Given the role and my competing offer, I am asking for 40,000 options and a 12-month post-departure exercise window subject to the original term. Please include the agreed terms in the approved grant documents.”
7. Confirm tax and modification effects before signing. Extending an exercise window, adding early exercise, or changing ISO terms can have tax and plan-modification consequences; resolve them before start date, not after.

Document-level details that still matter after the framework: If you push size, state the fully diluted denominator. On acceleration, negotiate amount, qualifying terminations, protection period, and non-assumption treatment—and get them into the approved award, not only the offer letter. A longer contractual post-departure exercise window can ease funding pressure but remains subject to the option’s ultimate term; for ISO treatment, Section 422(a)(2) generally uses three calendar months after employment ends (disability and death rules differ). Extending a granted option can be a modification requiring ISO/FMV retesting—see Treas. Reg. §1.424-1(e) and 409A extension rules. Early exercise can support earlier stock ownership and holding periods but requires funding before vesting; an early-exercisable option grant alone generally does not start an 83(b) deadline.

Can Senior Hires Negotiate Equity Refresh Grants?

Senior hires often ask—and sometimes receive—equity refresh grants. Practices vary; there is no legal entitlement. Do not treat a verbal “we refresh every year” as a committed award.

Ask: whether a program exists (policy vs. discretion); cadence and triggers (annual review, promotion, role change, financing); who recommends and who must approve; how size and dilution are modeled; and what is actually committed in writing versus aspirational. Get promised mechanics into the offer or a side letter consistent with the plan; the initial grant documents control until a later board-approved award. If size/timing will not be committed, at least document the review process.

05. Red Flags in Equity Offers

Watch for these warning signs (beyond the information gaps covered in the questions above):

Unsupported exercise price. Ask for the valuation method, effective date, and intervening material events. An independent appraisal is one valuation safe harbor, not a universal statutory requirement. Below-FMV NSOs can create Section 409A problems; above-FMV pricing is not itself a violation.

No discussion of the 83(b) decision when stock will be transferred. When restricted stock is transferred—including on early exercise into substantially nonvested shares—confirm who will evaluate the election, file it if appropriate, provide required copies, and retain proof. A grant of an early-exercisable option alone generally does not start the stock-transfer deadline. Do not assume the company is providing individual tax advice.

Verbal promises about equity. Get promised grants and future adjustments in writing and confirm the required approvals. Enforceability depends on the governing law and facts; the practical problem is proving the promise and reconciling it with the actual plan and award documents.

06. Taxes: What You Need to Know Before You Sign

Understand the tax consequences before accepting the grant, and revisit them before exercising or selling. The points below affect employee decisions; the linked guides cover the detailed rules.

ISOs vs. NSOs. Qualifying ISO exercise generally produces no regular federal compensation income, but an AMT adjustment may create tax before sale. An NSO exercise into vested stock generally produces ordinary income equal to FMV minus exercise price. A qualifying disposition generally requires holding at least two years from grant and one year from exercise; earlier sales are disqualifying dispositions with different tax results. Compare the actual spread, expected holding period, exercise funding, and sale risk rather than assuming ISOs always win. Details: the ISO vs. NSO guide.

The 83(b) election. For a transfer of substantially nonvested stock, consider the election promptly. The statutory deadline is 30 days after the actual property transfer, with no routine discretionary extension. An option or RSU grant alone generally transfers no stock. If you early-exercise an ISO, an 83(b) operates only for AMT purposes; the regular-tax election that matters is on restricted stock and early-exercised NSOs. See the 83(b) election guide.

The $100,000 ISO limit and >10% owners. Aggregate grant-date FMV of stock first exercisable in a calendar year; excess is treated as NSOs. First exercisability—not vesting or actual exercise—controls. Holders of more than 10% voting power face a 110% FMV exercise-price floor and a five-year maximum ISO term. Details are in the ISO/NSO guide.

QSBS. Holding an option generally does not start the Section 1202 stock holding period; acquisition typically occurs when you exercise and receive stock (subject to Section 83 rules). C-corp status, early exercise, or time alone does not promise QSBS treatment—issuer tests, original-issuance rules, active-business history, shareholder-level limits, and acquisition-date regimes all matter. Eligible-gain limits and exclusion percentages depend on acquisition date; they are not an automatic tax-free payout. For restricted stock subject to Section 83, a timely 83(b) generally starts the holding period just after transfer. See the QSBS guide.

07. Negotiation Mistakes to Avoid

Trading salary for equity without modeling cash needs. Evaluate both, but account for the difference between cash compensation and uncertain, potentially illiquid equity. Consider exercise funding and ability to bear a loss before reducing salary for a larger grant.

Comparing share counts across companies. Compare percentages, exercise prices, valuations, and estimated proceeds—not raw share counts.

Ignoring exercise cost and funding. Options require paying the exercise price to acquire the shares. Model whether you can fund exercise within the contractual window after a departure.

Treating tax and document details as afterthoughts. ISO vs. NSO, early exercise, 83(b) timing, and whether negotiated terms appear in the approved grant documents change outcomes. Resolve them before you start, not after.

Assuming your percentage stays fixed. Dilution from financings, conversions, and pool increases is ordinary—not a betrayal of the offer.

Conflating the contractual exercise window with ISO tax timing. A longer post-termination exercise right does not by itself preserve ISO treatment past Section 422’s statutory period.

Assuming an acquisition auto-accelerates vesting. Acceleration requires the document triggers (often double-trigger). Read them.

08. FAQ

How much equity should I ask for? Compare current offers or survey data for the role, stage, location, salary tradeoff, and grant duration. Negotiate using a stated fully diluted percentage, denominator, and calculation date—not generic role-and-stage percentage charts.

Can I negotiate equity after I’ve already accepted the offer? You can ask during a role change, compensation review, or financing. Your leverage depends on the circumstances. Before accepting is a useful time to resolve the initial package, but later changes may still be possible with the required approvals.

What if the company says equity grants are standardized and non-negotiable? Ask whether that applies to the grant amount, vesting, exercise window, and acceleration, or only some terms. If equity terms are fixed, consider salary or a signing bonus. Early-stage companies can also have firm policies.

Should I exercise my options early?
Compare the purchase cost, taxable spread, liquidity, forfeiture terms, and risk of losing the investment. A small purchase price does not establish a small taxable spread. Early exercise into restricted shares may make an 83(b) election important; ISO and NSO consequences differ. Potential QSBS eligibility and holding periods require separate review. There is no universal dollar cutoff at which early exercise becomes advisable.

How do I know if my equity will ever be worth anything?
You don't. Startup equity is high-risk. Evaluate it as part of total compensation and make sure base salary covers near-term needs.

What if I'm joining as a contractor, not an employee?
Contractors typically receive NSOs (not ISOs) or restricted stock, since ISOs may only be granted to employees. Pay particular attention to tax classification and when any QSBS holding period begins.

Is it common for senior hires to negotiate equity refreshers? Senior hires often ask about refresh grants; some companies have programs or discretionary refresh practices, others do not. There is no legal right to a refresher. Ask whether a program exists, the cadence and triggers, who approves, how size is set, and what—if anything—is committed in writing.

Negotiating Equity in Washington: State Tax Considerations

Washington has a capital gains tax under chapter 82.87 RCW and a separate 9.9% income tax under ESSB 6346 scheduled for January 1, 2028, unless repealed or struck down. Residency, sourcing, and recognition timing determine liability. Reconfirm the applicable year’s standard deduction before modeling.

Compare option types across both systems. A qualifying ISO sale generally produces long-term capital gain; an NSO can produce compensation at exercise and capital gain later. Those differences can matter across recognition years or a move. Federally excluded QSBS gain generally stays outside both Washington bases. Details: ISO vs. NSO, Washington tax on options and RSUs, and RSUs and Washington’s taxes.

Early exercise and timing. If the award permits early exercise, a timely 83(b) on restricted NSO shares or ordinary restricted stock measures the transfer-date spread; a pre-2028 transfer can place that compensation before the new income tax begins. Later gains can still be taxable in Washington. Model recognition timing—NSO exercise, restricted-stock vesting or 83(b) transfer, and RSU settlement—before trading an upfront grant for uncertain refreshers. See the 83(b) guide and exercise-timing guide.

QSBS. Gross-assets ceilings and exclusion regimes follow issuance and acquisition timing. Stock delivered on RSU settlement may qualify if the requirements are met; an RSU promise itself does not start stock ownership. See the QSBS guide.

Related Reading

• Startup Equity Compensation Guide
• ISO vs. NSO Stock Options: The Complete Guide
• The Complete Guide to 83(b) Elections
• 409A Valuation Guide
• Double-Trigger Acceleration
• Cap Table Management
• The Complete Guide to QSBS & Section 1202
• How Washington's 9.9% Income Tax Applies to Stock Options and RSUs

The Bottom Line

Evaluate the grant’s economics, documents, and tax consequences together—percentage on a stated fully diluted denominator, approved award documents that match what you negotiated, and the tax and exercise terms that determine whether you can actually realize value. Negotiation can improve terms; it cannot ensure the company succeeds or that common stock receives proceeds.

This post is for informational purposes only and does not constitute legal or tax advice. Consult with a qualified attorney and tax advisor regarding your specific circumstances.